T1	Condition 0 23	endometrial hyperplasia
T2	Condition 29 35	atypia
T3	Procedure 38 64	estrogen-progestin therapy
T4	Temporal 65 98	in the 2 months before enrollment
T5	Condition 101 120	autoimmune diseases
T6	Condition 123 130;166 175	chronic disorders
T7	Condition 132 141;166 175	metabolic disorders
T8	Condition 143 151;166 175	systemic disorders
T9	Condition 156 175	endocrine disorders
T10	Condition 187 203	hyperandrogenism
T11	Condition 205 223	hyperprolactinemia
T12	Condition 225 242	diabetes mellitus
T13	Condition 247 262	thyroid disease
*	OR T12 T13 T11 T10
T14	Scope 187 262	hyperandrogenism, hyperprolactinemia, diabetes mellitus and thyroid disease
T15	Scope 123 175	chronic, metabolic, systemic and endocrine disorders
R1	Subsumes Arg1:T15 Arg2:T14	
T16	Condition 265 294	hypogonadotropic hypogonadism
T17	Condition 297 323	majors clinical conditions
